• 

  Counting the Time Lived, the Time Left or Illness? Age, proximity to death, morbidity and prescribing expenditures 

  MOORE, PATRICK (2017)
• 

  Health Insurance, Healthcare Utilisation and Screening 

  MOORE, PATRICK (TILDA, 2017)
• European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease - The substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow 

  KENNY, ROSE; LAWLOR, BRIAN; COEN, ROBERT (2016)

  Introduction In conjunction with the NILVAD trial, a European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild-to-Moderate Alzheimer's disease (AD), there are four NILVAD substudies in which eligible ...
• Safety and tolerability of Tilt Testing and Carotid Sinus Massage in the octogenarians 

  KENNY, ROSE (2016)

  Objective: to evaluate the safety and tolerability of Tilt Testing (TT) and Carotid Sinus Massage (CSM) in octogenarians with unexplained syncope. Methods: patients consecutively referred for transient loss of consciousness ...
• Social disadvantage and social isolation are associated with a higher resting heart rate: evidence from The Irish Longitudinal Study on Ageing (TILDA) 

  LAYTE, RICHARD; KENNY, ROSE; FINUCANE, CIARAN (2015)

  OBJECTIVES: A high resting heart rate (RHR) represents a major risk factor for cardiovascular disease and individuals from poorer backgrounds have a higher RHR compared with their more advantaged peers. This study ...

View more